Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jiali Du, Jichun Gu, Junyuan Deng, Lei Kong, Yujie Guo, Chen Jin, Yun Bao, Deliang Fu & Ji Li. (2021) The Expression and Survival Significance of Glucose Transporter-1 in Pancreatic Cancer: Meta-Analysis, Bioinformatics Analysis and Retrospective Study. Cancer Investigation 39:9, pages 741-755.
Read now
Read now
Yasumitsu Hirose, Hiroaki Suefuji, Hayato Kaida, Masanobu Hayakawa, Satoshi Hattori, Seiji Kurata, Yuko Watanabe, Yukiko Kunou, Akihiko Kawahara, Takashi Okamura, Koichi Ohshima, Masayoshi Kage, Masatoshi Ishibashi & Naofumi Hayabuchi. (2014) Relationship between 2-deoxy-2-[18F]-fluoro-d-glucose uptake and clinicopathological factors in patients with diffuse large B-cell lymphoma. Leukemia & Lymphoma 55:3, pages 520-525.
Read now
Read now
George S Krasnov, Alexey A Dmitriev, Valentina A Lakunina, Alexander A Kirpiy & Anna V Kudryavtseva. (2013) Targeting VDAC-bound hexokinase II: a promising approach for concomitant anti-cancer therapy. Expert Opinion on Therapeutic Targets 17:10, pages 1221-1233.
Read now
Read now
Articles from other publishers (45)
Zhangyue Sun, Yongkang Li, Xiaolu Tan, Wanyi Liu, Xinglin He, Deyuan Pan, Enmin Li, Liyan Xu & Lin Long. (2023) Friend or Foe: Regulation, Downstream Effectors of RRAD in Cancer. Biomolecules 13:3, pages 477.
Crossref
Crossref
Chengcheng Wang, Ruiyuan Xu, Jianlu Song, Yuan Chen, Xinpeng Yin, Rexiati Ruze & Qiang Xu. (2022) Prognostic value of glycolysis markers in pancreatic cancer: A systematic review and meta-analysis. Frontiers in Oncology 12.
Crossref
Crossref
Claudia Curcio, Silvia Brugiapaglia, Sara Bulfamante, Laura Follia, Paola Cappello & Francesco Novelli. (2021) The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer. Molecules 26:6, pages 1642.
Crossref
Crossref
Lidong Cao, Jiacheng Wu, Xianzhi Qu, Jiyao Sheng, Mengying Cui, Shui Liu, Xu Huang, Yien Xiang, Bingjin Li, Xuewen Zhang & Ranji Cui. (2020) Glycometabolic rearrangements--aerobic glycolysis in pancreatic cancer: causes, characteristics and clinical applications. Journal of Experimental & Clinical Cancer Research 39:1.
Crossref
Crossref
Mar Achalandabaso Boira, Marcello Di Martino, Carlos Gordillo, Magdalena Adrados & Elena Martín-Pérez. (2020) GLUT-1 as a predictor of worse prognosis in pancreatic adenocarcinoma: immunohistochemistry study showing the correlation between expression and survival. BMC Cancer 20:1.
Crossref
Crossref
Debasmita Bhattacharya & Anthony Scimè. (2019) Metabolic Regulation of Epithelial to Mesenchymal Transition: Implications for Endocrine Cancer. Frontiers in Endocrinology 10.
Crossref
Crossref
Maria S. Fedorova, George S. Krasnov, Elena N. Lukyanova, Andrew R. Zaretsky, Alexey A. Dmitriev, Nataliya V. Melnikova, Alexey A. Moskalev, Sergey L. Kharitonov, Elena A. Pudova, Zulfiya G. Guvatova, Anastasiya A. Kobelyatskaya, Irina A. Ishina, Elena N. Slavnova, Anastasia V. Lipatova, Maria A. Chernichenko, Dmitry V. Sidorov, Anatoly Y. Popov, Marina V. Kiseleva, Andrey D. Kaprin, Anastasiya V. Snezhkina & Anna V. Kudryavtseva. (2019) The CIMP-high phenotype is associated with energy metabolism alterations in colon adenocarcinoma. BMC Medical Genetics 20:S1.
Crossref
Crossref
Min Yu, Shengying Chen, Weifeng Hong, Yujun Gu, Bowen Huang, Ye Lin, Yu Zhou, Haosheng Jin, Yanying Deng, Lei Tu, Baohua Hou & Zhixiang Jian. (2019) Prognostic role of glycolysis for cancer outcome: evidence from 86 studies. Journal of Cancer Research and Clinical Oncology 145:4, pages 967-999.
Crossref
Crossref
P. E. Tulin, M. B. Dolgushin, D. I. Nevzorov, P. V. Kochergin & Yu. I. Patyutko. (2018) PET/CT IN THE DIAGNOSIS OF PANCREATIC CANCER: LITERATURE REVIEW. Medical Visualization:1, pages 57-67.
Crossref
Crossref
Zheng-Xiao Zhao, Lin-Wei Lu, Jian Qiu, Qiu-Ping Li, Fei Xu, Bao-Jun Liu, Jing-Cheng Dong & Wei-Yi Gong. (2017) Glucose transporter-1 as an independent prognostic marker for cancer: a meta-analysis. Oncotarget 9:2, pages 2728-2738.
Crossref
Crossref
Akira Chikamoto, Risa Inoue, Yoshiaki Komohara, Kentaro Sakamaki, Daisuke Hashimoto, Shinya Shiraishi, Hiroshi Takamori, Yo-ichi Yamashita, Naoya Yoshida, Takeharu Yamanaka, Yasuyuki Yamashita & Hideo Baba. (2017) Preoperative High Maximum Standardized Uptake Value in Association with Glucose Transporter 1 Predicts Poor Prognosis in Pancreatic Cancer. Annals of Surgical Oncology 24:7, pages 2040-2046.
Crossref
Crossref
Min Yu, Han Yongzhi, Shengying Chen, Xiaodan Luo, Ye Lin, Yu Zhou, Haosheng Jin, Baohua Hou, Yanying Deng, Lei Tu & Zhixiang Jian. (2017) The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis. Oncotarget 8:26, pages 43356-43367.
Crossref
Crossref
Cristoforo Grasso, Gerrit Jansen & Elisa Giovannetti. (2017) Drug resistance in pancreatic cancer: Impact of altered energy metabolism. Critical Reviews in Oncology/Hematology 114, pages 139-152.
Crossref
Crossref
Jiayuan Wu, Liren Hu, Fenping Wu, Lei Zou & Taiping He. (2017) Poor prognosis of hexokinase 2 overexpression in solid tumors of digestive system: a meta-analysis. Oncotarget 8:19, pages 32332-32344.
Crossref
Crossref
Gaowa Sharen, Yaojun Peng, Haidong Cheng, Yang Liu, Yonghong Shi & Jian Zhao. (2017) Prognostic value of GLUT-1 expression in pancreatic cancer: results from 538 patients. Oncotarget 8:12, pages 19760-19767.
Crossref
Crossref
Andrea Morandi, Maria Letizia Taddei, Paola Chiarugi & Elisa Giannoni. (2017) Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors. Frontiers in Oncology 7.
Crossref
Crossref
Hai-Jing Yang, Wei-Jia Xu, Yi-Hui Guan, Hui-Wei Zhang, Wei-Qun Ding, Lan Rong, Zhi-Bing Qiu & Liang Zhong. (2016) Expression of Glut-1 and HK-II in Pancreatic Cancer and Their Impact on Prognosis and FDG Accumulation. Translational Oncology 9:6, pages 583-591.
Crossref
Crossref
Yulin Liu, Ke Wu, Liang Shi, Fan Xiang, Kaixiong Tao & Guobin Wang. (2016) Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis. PLOS ONE 11:11, pages e0166230.
Crossref
Crossref
Alenoush Vartanian, Sameer Agnihotri, Mark R. Wilson, Kelly E. Burrell, Peter D. Tonge, Amir Alamsahebpour, Shahrzad Jalali, Michael S. Taccone, Sheila Mansouri, Brian Golbourn, Kenneth D. Aldape & Gelareh Zadeh. (2016) Targeting hexokinase 2 enhances response to radio-chemotherapy in glioblastoma. Oncotarget 7:43, pages 69518-69535.
Crossref
Crossref
Pablo Moreno‑Acosta, Schyrly Carrillo, Oscar Gamboa, Alfredo Romero‑Rojas, Jinneth Acosta, Monica Molano, Joseph Balart‑Serra, Martha Cotes, Chlo� Rancoule & Nicolas Magn�. (2016) Novel predictive biomarkers for cervical cancer prognosis. Molecular and Clinical Oncology.
Crossref
Crossref
Ashley H. Davis-Yadley, Andrea M. Abbott, Jose M. Pimiento, Dung-Tsa Chen & Mokenge P. Malafa. (2016) Increased Expression of the Glucose Transporter Type 1 Gene Is Associated With Worse Overall Survival in Resected Pancreatic Adenocarcinoma. Pancreas 45:7, pages 974-979.
Crossref
Crossref
Xiaohua Xing, Dong Liang, Yao Huang, Yongyi Zeng, Xiao Han, Xiaolong Liu & Jingfeng Liu. (2016) The application of proteomics in different aspects of hepatocellular carcinoma research. Journal of Proteomics 145, pages 70-80.
Crossref
Crossref
Runze Shang, Jianlin Wang, Wei Sun, Bin Dai, Bai Ruan, Zhuochao Zhang, Xisheng Yang, Yuan Gao, Shibin Qu, Xing Lv, Kaishan Tao, Lin Wang, Kefeng Dou & Desheng Wang. (2015) RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma. Tumor Biology 37:4, pages 5097-5105.
Crossref
Crossref
Anthony KC Chan, Jason IE Bruce & Ajith K Siriwardena. (2016) Glucose metabolic phenotype of pancreatic cancer. World Journal of Gastroenterology 22:12, pages 3471-3485.
Crossref
Crossref
Nelson Ho & Brenda L. Coomber. (2016) Hexokinase II expression is correlated with colorectal cancer prognosis. Cancer Treatment Communications 6, pages 11-16.
Crossref
Crossref
G. S. Krasnov, A. A. Dmitriev, A. F. Sadritdinova, M. S. Fedorova, A. V. Snezhkina, N. V. Melnikova, A. V. Poteryakhina, K. M. Nyushko, M. M. Belyakov, A. D. Kaprin, A. R. Zaretsky & A. V. Kudryavtseva. (2016) Evaluation of hexokinase gene expression in colorectal cancer using bioinformatics tools. Biophysics 60:6, pages 870-875.
Crossref
Crossref
Xiaohua Xing, Yao Huang, Sen Wang, Minhui Chi, Yongyi Zeng, Lihong Chen, Ling Li, Jinhua Zeng, Minjie Lin, Xiao Han, Xiaolong Liu & Jingfeng Liu. (2015) Comparative analysis of primary hepatocellular carcinoma with single and multiple lesions by iTRAQ-based quantitative proteomics. Journal of Proteomics 128, pages 262-271.
Crossref
Crossref
DAPENG ZHANG, LIHUA CUI, SHU SHUN LI & FENG WANG. (2015) Insulin and hypoxia-inducible factor-1 cooperate in pancreatic cancer cells to increase cell viability. Oncology Letters 10:3, pages 1545-1550.
Crossref
Crossref
Hisataka Ogawa, Hiroaki Nagano, Masamitsu Konno, Hidetoshi Eguchi, Jun Koseki, Koichi Kawamoto, Naohiro Nishida, Hugh Colvin, Akira Tomokuni, Yoshito Tomimaru, Naoki Hama, Hiroshi Wada, Shigeru Marubashi, Shogo Kobayashi, Masaki Mori, Yuichiro Doki & Hideshi Ishii. (2015) The combination of the expression of hexokinase�2 and pyruvate kinase M2 is a prognostic marker in patients with pancreatic cancer. Molecular and Clinical Oncology.
Crossref
Crossref
Atsushi Hamabe, Hirofumi Yamamoto, Masamitsu Konno, Mamoru Uemura, Junichi Nishimura, Taishi Hata, Ichiro Takemasa, Tsunekazu Mizushima, Naohiro Nishida, Koichi Kawamoto, Jun Koseki, Yuichiro Doki, Masaki Mori & Hideshi Ishii. (2014) Combined evaluation of hexokinase 2 and phosphorylated pyruvate dehydrogenase‐E1α in invasive front lesions of colorectal tumors predicts cancer metabolism and patient prognosis. Cancer Science 105:9, pages 1100-1108.
Crossref
Crossref
Dong Hoon Suh, Min A. Kim, Haeryoung Kim, Mi-Kyung Kim, Hee Seung Kim, Hyun Hoon Chung, Yong-Beom Kim & Yong Sang Song. (2013) Association of overexpression of hexokinase II with chemoresistance in epithelial ovarian cancer. Clinical and Experimental Medicine 14:3, pages 345-353.
Crossref
Crossref
Zhong Li. (2013) CD133: a stem cell biomarker and beyond. Experimental Hematology & Oncology 2:1.
Crossref
Crossref
Pablo Moreno-Acosta, Schyrly Carrillo, Oscar Gamboa, Yineth Acosta, Joseph Balart-Serra, Nicolas Magne, Mario Alexander Melo-Uribe & Alfredo Ernesto Romero-Rojas. (2013) Expresión de marcadores hipóxicos y glucolíticos CAIX, GLUT-1, HKII y su relación con la respuesta temprana al tratamiento en carcinoma escamocelular de cuello uterino. Progresos de Obstetricia y Ginecología 56:8, pages 404-413.
Crossref
Crossref
Hye Jin ChoiChang Moo KangWoo Jung LeeSi Young SongArthur ChoMijin YunJong Doo LeeJoo Hang KimJae-Hoon Lee. (2013)
Prognostic Value of
18
F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Resectable Pancreatic Cancer
. Yonsei Medical Journal 54:6, pages 1377.
Crossref
Crossref
Lei Gong, Zhuqingqing Cui, Pengcheng Chen, Hui Han, Jirun Peng & Xisheng Leng. (2011) Reduced survival of patients with hepatocellular carcinoma expressing hexokinase II. Medical Oncology 29:2, pages 909-914.
Crossref
Crossref
Jai Hyuen Lee, Won Ae Lee, Seok Gun Park, Dong Kook Park & Hwan Namgung. (2012) Relationship Between Dual-Time Point FDG PET and Immunohistochemical Parameters in Preoperative Colorectal Cancer: Preliminary Study. Nuclear Medicine and Molecular Imaging 46:1, pages 48-56.
Crossref
Crossref
Federica Sotgia, Ubaldo E. Martinez-OutschoornAnthony Howell, Richard G. PestellStephanos Pavlides & Michael P. Lisanti. (2012) Caveolin-1 and Cancer Metabolism in the Tumor Microenvironment: Markers, Models, and Mechanisms. Annual Review of Pathology: Mechanisms of Disease 7:1, pages 423-467.
Crossref
Crossref
Eduardo J. Folco, Yuri Sheikine, Viviane Z. Rocha, Thomas Christen, Eugenia Shvartz, Galina K. Sukhova, Marcelo F. Di Carli & Peter Libby. (2011) Hypoxia But Not Inflammation Augments Glucose Uptake in Human Macrophages. Journal of the American College of Cardiology 58:6, pages 603-614.
Crossref
Crossref
Olca Basturk, Rajendra Singh, Ecmel Kaygusuz, Serdar Balci, Nevra Dursun, Nil Culhaci & N. Volkan Adsay. (2011) GLUT-1 Expression in Pancreatic Neoplasia. Pancreas 40:2, pages 187-192.
Crossref
Crossref
Xiaoqun Dong, Hongwei Tang, Kenneth R. Hess, James L. Abbruzzese & Donghui Li. (2010) Glucose metabolism gene polymorphisms and clinical outcome in pancreatic cancer. Cancer 117:3, pages 480-491.
Crossref
Crossref
Ji-Youn Sung, Gou Young Kim, Sung-Jig Lim, Yong-Koo Park & Youn Wha Kim. (2010) Expression of the GLUT1 glucose transporter and p53 in carcinomas of the pancreatobiliary tract. Pathology - Research and Practice 206:1, pages 24-29.
Crossref
Crossref
Diane Palmieri, Daniel Fitzgerald, S. Martin Shreeve, Emily Hua, Julie L. Bronder, Robert J. Weil, Sean Davis, Andreas M. Stark, Maria J. Merino, Raffael Kurek, H. Maximilian Mehdorn, Gary Davis, Seth M. Steinberg, Paul S. Meltzer, Kenneth Aldape & Patricia S. Steeg. (2009) Analyses of Resected Human Brain Metastases of Breast Cancer Reveal the Association between Up-Regulation of Hexokinase 2 and Poor Prognosis. Molecular Cancer Research 7:9, pages 1438-1445.
Crossref
Crossref
Tatsuya Higashi. 2009. Gastrointestinal Carcinoma. Gastrointestinal Carcinoma
191
203
.
Satoru Seo, Ryuichiro Doi, Takafumi Machimoto, Kazuhiro Kami, Toshihiko Masui, Etsuro Hatano, Kohei Ogawa, Tatsuya Higashi & Shinji Uemoto. (2008) Contribution of 18F-fluorodeoxyglucose positron emission tomography to the diagnosis of early pancreatic carcinoma. Journal of Hepato-Biliary-Pancreatic Surgery 15:6, pages 634-639.
Crossref
Crossref
Yusu Xie, Bing Wang, Fuhua Li, Hao Jiang & Jianhai Xiang. (2008) Molecular cloning and characterization of proliferating cell nuclear antigen (PCNA) from Chinese shrimp Fenneropenaeus chinensis. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology 151:2, pages 225-229.
Crossref
Crossref